Professor Ian Kimber, University of Manchester, has been appointed as the new Chair of the Board of the NC3Rs.
Professor Kimber will lead the Board, which oversees policy and strategy and is consulted on major spending decisions, from 3 July 2008 for a three year term. He replaces Lord Turnberg of Cheadle, who led the Board from May 2004 till October 2007(2).
Ian Pearson, Minister of State for Science and Innovation, said: "I have been delighted to support the work of the NC3Rs, including the increased funding we have recently provided. I want to see the NC3Rs continue to play an important role in the Government's strategy to ensure that UK science is the best and most humane in the world.
"I am impressed by the support that the NC3Rs has received from universities and industry. Ian Kimber's breadth of experience in both these communities makes him an excellent choice to lead the NC3Rs."
Professor Ian Kimber said: "Since its launch, the NC3Rs has been successful far beyond initial expectations. I'm immensely proud to be able to play a part in building on that success. The NC3Rs has legitimised further research into the development of alternative methods, and encouraged a more open and constructive debate within the scientific community about the use of animals.
"The Centre is also uniquely placed to ensure that advances in science and technology are exploited fully for the delivery of replacements, reductions and refinements."
Dr Vicky Robinson, Chief Executive of the NC3Rs, said: "Ian is one of the few scientists to combine a career in academia and industry, with the development of a validated alternative to toxicology testing which has been accepted by regulators worldwide and helped reduce animal testing. He has, for many years, been a leading proponent of the 3Rs and will be a great ambassador for the work of the NC3Rs."
Notes for Editors:
- The NC3Rs currently receives nearly £3.5 million from the Department for Innovation, Universities and Skills (DIUS) via the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC). In December 2007, Ian Pearson announced that this will increase each year to just over £5 million by 2010/11.
- In the interim, the role of Acting Chair has been undertaken by Professor Paul Flecknell, Director of the Comparative Biology Centre, Newcastle University.
- The NC3Rs has a non-executive Board which oversees the NC3Rs policy and strategy, ensures that the organisation is effectively managed, and is consulted on major spending decisions. Specifically, the Board: 1) advises on and approves the NC3Rs work plan; and 2) monitors the performance of the NC3Rs against its mission statement and agreed objectives. The Board meets three times a year. The current membership can be found here.
- Professor Ian Kimber is Professor of Toxicology, Faculty of Life Sciences, University of Manchester. He was previously Head of Research and Principal Fellow at the Syngenta Central Toxicology Laboratory. He serves, or has served, on a number of national and international scientific and advisory committees. Currently these include: the Medicines and Healthcare products Regulatory Agency (MHRA) Committee for the Safety of Devices, the Medical Research Council (MRC) Training and Careers Group, and the Executive Committee of the British Toxicology Society. He is Special Advisor on Industrial Liaison to the MRC and Advisor to the Food Standards Agency research programme on food allergy and intolerance.
- Professor Kimber is also a Trustee of FRAME (Fund for the Replacement of Animals in Medical Experiments) and his team lead the design, development and validation of an alternative method for testing for skin sensitisation the Local Lymph Node Assay (LLNA).
- Professor Kimber has published more than 500 peer-reviewed research papers, review articles and book chapters and is author/editor of six books, including 2nd and 3rd editions of Immunotoxicology and Immunopharmacology. He has given more than 1,300 presentations at national and international conferences, symposia, colloquia and workshops. He is currently on the editorial boards of the science journals Toxicology, Immunology, Pathology, and Alternatives to Laboratory Animals.